Ling Lei
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pathology and Forensic Medicine top 10%
- Systemic Sclerosis and Related Diseases
Papers in
-
- Systemic Sclerosis and Related Diseases 16
- Autoimmune Bullous Skin Diseases 2
- Co-authors
- Xuejing Zou (5 shared papers)Dehua Wu (4 shared papers)Cheng Zhao (12 shared papers)Li Liu (3 shared papers)Dongyan Zhang (3 shared papers)Xu Wang (1 shared paper)Zhiyi He (1 shared paper)Xiao-ning Zhong (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Clinical Rheumatology (2 papers)Oncogene (2 papers)Anatomical Science International (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ling Lei
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 298
- Pathology and Forensic Medicine 146
- Molecular Biology 502
- Dermatology 55
- Immunology 120
Countries citing papers authored by Ling Lei
This map shows the geographic impact of Ling Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lei more than expected).
Fields of papers citing papers by Ling Lei
This network shows the impact of papers produced by Ling Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lei. The network helps show where Ling Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. | 2000 | 183 |
| 2 | 2016 | 151 | |
| 3 | Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. | 2017 | 120 |
| 4 | 2018 | 99 | |
| 5 | 2016 | 78 | |
| 6 | 2018 | 74 | |
| 7 | 2020 | 29 | |
| 8 | 2018 | 29 | |
| 9 | 2016 | 29 | |
| 10 | 2021 | 27 | |
| 11 | 2017 | 27 | |
| 12 | 2014 | 25 | |
| 13 | 2018 | 21 | |
| 14 | 2014 | 17 | |
| 15 | 2020 | 13 | |
| 16 | 2019 | 12 | |
| 17 | 2014 | 12 | |
| 18 | Comparison between the efficacy of combination therapy and monotherapy in connective tissue disease associated pulmonary arterial hypertension: a systematic review and meta-analysis. | 2019 | 10 |
| 19 | 2019 | 9 | |
| 20 | 2022 | 7 |
About Ling Lei
Ling Lei is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Rheumatology, Cancer Research and Surgery, having authored 42 papers that have together received 1.0k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (16 papers), Pelvic floor disorders treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), MicroRNA in disease regulation (3 papers), Autoimmune Bullous Skin Diseases (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (298 citations), Pathology and Forensic Medicine (146 citations), Molecular Biology (502 citations), Dermatology (55 citations) and Immunology (120 citations). Ling Lei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xuejing Zou, Dehua Wu, Cheng Zhao, Li Liu, Dongyan Zhang, Xu Wang, Zhiyi He, Xiao-ning Zhong, Liwei Xie and M R Spitz. Their work appears in journals such as Frontiers in Immunology, Clinical Rheumatology, Oncogene, Anatomical Science International and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.